2-(苯甲酰基氨基)苯甲酸 | 579-93-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(苯甲酰基氨基)苯甲酸
• 英文名称: 2-(Benzoylamino)benzoic Acid
• 英文别名: 2-benzamidobenzoic acid
• CAS: 579-93-1
• 化学式: C₁₄H₁₁NO₃
• mdl: MFCD00444173
• 分子量: 241.246
• InChiKey: WXVLIIDDWFGYCV-UHFFFAOYSA-N

物化性质

• 熔点：
  178 °C
• 沸点：
  341.9±25.0 °C(Predicted)
• 密度：
  1.334±0.06 g/cm3(Predicted)
• LogP：
  3.42
• 物理描述：
  White solid; fruity aroma
• 溶解度：
  Slightly soluble in water

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(Benzoylamino)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(Benzoylamino)benzoic acid
CAS number: 579-93-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C14H11NO3
Molecular weight: 241.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(苯甲酰基氨基)苯甲酸 在 ammonium hydroxide 作用下， 以 乙醇 、 乙酸酐 为溶剂， 反应 2.0h， 生成 2-苯基-4-[3H]喹唑啉酮
  参考文献：
  名称：

  Lee, Eung Seok; Son, Jong Keun; Na, Young Hwa, Heterocyclic Communications, 2004, vol. 10, # 4-5, p. 325 - 330

  摘要：

  DOI：
• 作为产物：
  描述：

  2-苯基吲哚-3-酮 在 双氧水 作用下， 以 二甲基亚砜 为溶剂， 反应 21.0h， 以37%的产率得到2-(苯甲酰基氨基)苯甲酸
  参考文献：
  名称：

  铜介导的氧化串联反应一锅法从2-芳基吲哚一锅合成多氢吡啶并[1,2- a ]吲哚和四环喹唑啉酮

  摘要：

  我们开发了一种简便的一锅法，将2-芳基吲哚转化为多氢吡啶并[1,2- a ]吲哚和四环喹唑啉酮。铜催化的2-芳基吲哚氧化为C-酰基亚胺，然后进行aza-Diels-Alder反应或氧化性扩环反应，得到了显着的多环杂环。

  DOI：

  10.1016/j.tet.2016.05.054

文献信息

• Synthetic Applications of Pd(II)-Catalyzed C−H Carboxylation and Mechanistic Insights: Expedient Routes to Anthranilic Acids, Oxazolinones, and Quinazolinones
  作者：Ramesh Giri、Jonathan K. Lam、Jin-Quan Yu

  DOI：10.1021/ja9077705

  日期：2010.1.20

  carbon monoxide is discussed. Identification of two key intermediates, a mixed anhydride and benzoxazinone formed by reductive elimination from organometallic Ar(CO)Pd(II)-OTs species, provides mechanistic evidence for a dual-reaction pathway.

  已经开发了一种 Pd(II) 催化的反应方案，用于将苯胺中的邻位 CH 键羧化以形成 N-酰基邻氨基苯甲酸。该反应过程为从简单的苯胺快速组装具有生物学和药学意义的分子（例如苯并恶嗪酮和喹唑啉酮）提供了一种新颖且有效的策略，而无需安装和去除外部导向基团。反应条件也适用于 N-苯基吡咯烷酮的羧化。含有对甲苯磺酸盐作为阴离子配体的单体钯环已通过 X 射线晶体学表征，并讨论了对甲苯磺酸在一氧化碳存在下活化 CH 键中的关键作用。鉴定两个关键中间体，
• [EN] FUSED QUINOLINE DERIVATIVE AND USE THEREOF<br/>[FR] DÉRIVÉ DE QUINOLINE FUSIONNÉE ET UTILISATION DE CELUI-CI
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005105802A1

  公开（公告）日：2005-11-10

  The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) wherein Rl is a hydrogen atom and the like; R2 is a hydrogen atom, a hydrocarbon group optionally having substituent(s) and the like; R3 is unsubstituted (i.e., absence), a hydrogen atom and the like; R4 and R5 are the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s), and the like; R6 is (cyclic group optionally having substituent(s)) -carbonyl, and the like; R7, R8, R9 and R10 are the same or different and each is a hydrogen atom, halogen and the like; or R7 and R8, R8 and R9, and R9 and R10 may form a ring together with the adjacent carbon atoms; n is an integer of 1 to 5; --- represents unsubstituted (i.e., absence) or a single bond; and --- represents a single bond or a double bond, or a salt thereof, and the like.

  本发明旨在提供一种具有神经激肽2（NK2）受体拮抗作用的喹啉衍生物，并涉及一种由式（I）表示的化合物，其中R1是氢原子等；R2是氢原子，可选地具有取代基的碳氢基团等；R3是未取代的（即缺失），氢原子等；R4和R5相同或不同，每个是氢原子，可选地具有取代基的碳氢基团等；R6是（环状基团，可选地具有取代基）-羰基等；R7、R8、R9和R10相同或不同，每个是氢原子，卤素等；或R7和R8、R8和R9、以及R9和R10可以与相邻的碳原子一起形成环；n是1到5的整数；---表示未取代的（即缺失）或单键；---表示单键或双键，或其盐等。
• Substituent Effects on Energetics of Peptide-Carboxylate Hydrogen Bonds as Studied by ¹H NMR Spectroscopy: Implications for Enzyme Catalysis
  作者：Bright U. Emenike、Albert Tianxiang Liu、Elsy P. Naveo、John D. Roberts

  DOI：10.1021/jo401762m

  日期：2013.12.6

  Substituent effects in N–H···O hydrogen bonds were estimated by comparing the acidities of two series of model compounds: N-benzoylanthranilic acids (A) and 4-benzoylamidobenzoic acids (B). Intramolecular N–H···O hydrogen bonds were found to be present in the A series of compounds, while B acids were used as control models. The respective pKa values for A and B acids were determined experimentally

  ：在N-H ... O氢键键取代基的效果通过比较的两个系列的模型化合物的酸度估计Ñ -benzoylanthranilic酸（甲）和4- benzoylamidobenzoic酸（乙）。发现在A系列化合物中存在分子内N–H··O氢键，而将B酸用作对照模型。使用质子NMR光谱在DMSO溶液中通过实验确定A和B酸的相应p K a值。其中X = H，在p ķ一个为阿和乙酸观察为7.6和11.6，分别为4.0单位（ΔP的差ķ一个）。然而，随着X = p -NO 2，该ΔP ķ一个之间值甲和乙酸增加至4.7单位：所述p ķ一个为值甲和乙酸被分别确定为6.7和11.4。的ΔP ķ一之间的值甲和乙作为X的取代基的一个功能酸用在其他实施例10研究了。X取代基在A中的作用可以根据观察到的线性Hammett相关性预测酸，并且发现每个取代基效应的敏感性都与被取代的苯甲酸电离所观察到的敏感性相当（A酸的ρ= 1.04
• Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
  申请人：——

  公开号：US20020143191A1

  公开（公告）日：2002-10-03

  Process for the preparation of stable activated derivatives of carbamic acid, comprising at least one protected amino group and an activated carbamic acid function, from an amino acid derivative in which the amino group is protected. The process includes: a) a step of transformation of the —COOH group of the amino acid derivative into a —CON 3 group to obtain an acyl azide; b) a step of transformation of the —CON 3 group of the acyl azide into a —NCO group to obtain an isocyanate; c) a step of treating the isocyanate to obtain a stable derivative of carbamic acid.

  制备稳定活化的氨基甲酸衍生物的过程，包括至少一个受保护的氨基团和一个活化的氨基甲酸功能，从氨基酸衍生物中，其中氨基团被保护。该过程包括：a) 将氨基酸衍生物的—COOH基团转化为—CON3基团以获得酰基叠氮化合物；b) 将酰基叠氮化合物的—CON3基团转化为—NCO基团以获得异氰酸酯；c) 处理异氰酸酯以获得稳定的氨基甲酸衍生物。
• Acylated 1<i>H</i>-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action
  作者：Marvin Korff、Lukas Imberg、Jonas M. Will、Nico Bückreiß、Svetlana A. Kalinina、Benjamin M. Wenzel、Gregor A. Kastner、Constantin G. Daniliuc、Maximilian Barth、Ruzanna A. Ovsepyan、Kirill R. Butov、Hans-Ulrich Humpf、Matthias Lehr、Mikhail A. Panteleev、Antti Poso、Uwe Karst、Torsten Steinmetzer、Gerd Bendas、Dmitrii V. Kalinin

  DOI：10.1021/acs.jmedchem.0c01635

  日期：2020.11.12

  We herein report the conventional and microscale parallel synthesis of selective inhibitors of human blood coagulation factor XIIa and thrombin exhibiting a 1,2,4-triazol-5-amine scaffold. Structural variations of this scaffold allowed identifying derivative 21i, a potent 29 nM inhibitor of FXIIa, with improved selectivity over other tested serine proteases and also finding compound 21m with 27 nM

  我们在此报告了常规和微观并行合成的人类凝血因子XIIa和凝血酶的选择性抑制剂，这些抑制剂表现出1,2,4-三唑-5-胺骨架。该支架的结构变异允许鉴定衍生物21i（一种有效的FXIIa抑制剂29nM），具有比其他经过测试的丝氨酸蛋白酶更高的选择性，还可以发现化合物21m对凝血酶具有27 nM的抑制活性。首次证明酰化的1,2,4-三唑-5-胺具有抗凝特性，并具有影响凝血酶和癌细胞诱导的血小板凝集的能力。进行的质谱分析和分子建模使我们能够发现合成的抑制剂与FXIIa活性位点之间以前未知的相互作用，从而揭示了FXIIa抑制的机理细节。合成的化合物代表了开发新的抗血栓药物或化学工具以研究FXIIa和凝血酶在生理和病理过程中的作用的有希望的起点。